Jul 2 |
HOOKIPA Pharma doses first subject in Phase Ib HIV treatment trial
|
Jul 1 |
HOOKIPA Pharma Announces First Person Dosed in Phase 1b Clinical Trial of HB-500 for the Treatment of HIV
|
Jun 5 |
Keurig Dr Pepper To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Wednesday
|
Jun 4 |
HOOKIPA Pharma Announces Updated Phase 2 Clinical Data at the American Society of Clinical Oncology 2024 Annual Meeting
|
May 30 |
HOOKIPA Pharma to Host Investor Call on HB-200 Data Presented at American Society of Clinical Oncology 2024 Annual Meeting
|
May 24 |
HOOKIPA stock falls 20% in wake of Phase 1/2 study results
|
May 23 |
HOOKIPA Pharma Announces Positive Clinical Data to be Presented at the American Society for Clinical Oncology 2024 Annual Meeting
|
May 16 |
Penny Stock Sleepers: 7 Under-the-Radar Gems Ready to Launch
|
May 11 |
HOOKIPA Pharma First Quarter 2024 Earnings: Beats Expectations
|
May 9 |
HOOKIPA Pharma GAAP EPS of $0.11
|